A Move in the Light Direction

What Safety Measures Will Guests Expect as Travel Booms this Summer?

On this episode of A Move In The Light Direction, a podcast by Surfacide UV Technology, host Daniel Litwin talked with Wendy Walling, Director of Global Marketing at Intellego Technologies, and Jeff Veenhuis, President and CEO, Surfacide Manufacturing. The trio spoke about trends in summer travels as the U.S. meets new highs in travel demand…

Read More

Latest

A Move in the Light Direction
Is UVC the Future of Infection Prevention Technology?

The risk of cross-contamination and mass infections in healthcare settings has always been an issue, but in the midst of a raging pandemic, that problem has been exacerbated even further. However, with many hospitals, nursing homes and other healthcare facilities already stretched thin, an affordable solution that requires minimal time and effort to use is…

Read More
A Move in the Light Direction
Easing the PPE Strain During the Pandemic

During the early days of the pandemic, one of the healthcare community’s challenges was a critical lack of PPE to fight the coronavirus. Ryan Madewell, Director of Environmental Services at Hunt Regional Healthcare for Vanguard Resources, spoke about this problem and how Surfacide’s UV-C solutions helped keep front-line workers and patients safe. Even before…

Read More
A Move in the Light Direction
How Healthcare Organizations Are Navigating Compliance Challenges during the COVID Pandemic

The COVID-19 pandemic has strained healthcare systems and those who work in them all over the world. But, with more patients and more work, there cannot be a reduction in standards or compliance. Rich Feczko, National Director of Standards & Innovation for Compass One Healthcare, is one of many mourning the recent loss of…

Read More
A Move in the Light Direction
UV-C’s Role in Fighting COVID-19

Multidrug-resistant pathogens are an increasing concern in healthcare. Finding new ways and technologies to fight these pathogens is what led Gunner Lyslo to create Surfacide UV-C, an infection prevention solution. Lyslo, Founder and CEO of Surfacide, spoke to Tyler Kern about the technology’s ability to play a role in fighting COVID-19. Lyslo developed Surfacide…

Read More

Latest

Texas
Up Next: Demographic Change, Education, and the Future of Texas and the Nation
December 2, 2025

Houston’s unmatched diversity and rapidly growing young population are reshaping the city’s economic future — and offering clues about what’s ahead for the nation. In the upcoming episode of Weaver: Beyond the Numbers, the conversation explores how immigration, education, and demographic momentum intersect to create extraordinary opportunities when supported with the right investments.

Read More
patient
Rebecca Interview: When Peer-to-Peer Reviews Stop Being About the Patient
December 2, 2025

Behind the sterile labels of “inpatient” versus “observation” care is a messy reality: clinicians and insurers often enter peer-to-peer reviews without a shared rulebook, turning what should be a clinical dialogue into a box-checking exercise. The speaker’s frustration points to a broader problem in U.S. healthcare utilization management—decisions about coverage can feel pre-decided,…

Read More
physician advisor
Navigating Payer Denials: A Physician Advisor’s Perspective #2
December 2, 2025

A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…

Read More
Navigating Payer Denials: A Physician Advisor’s Perspective #1
December 2, 2025

America’s healthcare system is buckling under a contradiction we’ve normalized: we expect reliable care for roughly 380 million people while letting every major lever of the system be pulled by for-profit players chasing the same dollar. In any market, companies will optimize for profit, but in medicine that instinct collides with a rulebook…

Read More